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The RNA helicases DDX5 and DDX17 aremembers of
a large family of highly conserved proteins that are
involved in gene-expression regulation; however,
their in vivo targets and activities in biological pro-
cesses such as cell differentiation, which requires
reprogramming of gene-expression programs at
multiple levels, are not well characterized. Here, we
uncovered a mechanism by which DDX5 and
DDX17 cooperate with heterogeneous nuclear ribo-
nucleoprotein (hnRNP) H/F splicing factors to define
epithelial- and myoblast-specific splicing subpro-
grams. We then observed that downregulation of
DDX5 and DDX17 protein expression during myo-
genesis and epithelial-to-mesenchymal transdiffer-
entiation contributes to the switching of splicing
programs during these processes. Remarkably, this
downregulation is mediated by the production of
miRNAs induced upon differentiation in a DDX5/
DDX17-dependent manner. Since DDX5 and DDX17
also function as coregulators of master transcrip-
tional regulators of differentiation, we propose to
name these proteins ‘‘master orchestrators’’ of dif-
ferentiation that dynamically orchestrate several
layers of gene expression.INTRODUCTION
Transcriptome reprogramming during cell differentiation in-
volves multiple layers of regulation of the gene-expression pro-
cess, including transcription, alternative splicing that expands
the gene message, and miRNAs that control mRNA stability
and translation (Ebert and Sharp, 2012; Kalsotra and Cooper,1900 Cell Reports 7, 1900–1913, June 26, 2014 ª2014 The Authors2011). These different gene-expression layers are usually
analyzed independently, even though many factors that partici-
pate in several of these layers have been identified. Yet, evi-
dence that a single factor orchestrates several gene-expression
layers during cell differentiation is still lacking.
The DEAD box RNA helicase DDX5 and its paralog, DDX17,
are highly conserved proteins that function in most steps of the
gene-expression process, although their in vivo targets and ac-
tivities are not fully characterized (Fuller-Pace and Moore, 2011;
Janknecht, 2010; Linder and Jankowsky, 2011). They are core-
gulators of several transcription factors, includingMYOD, amas-
ter regulator of muscle differentiation (Caretti et al., 2006), and
SMAD proteins (Warner et al., 2004; Davis et al., 2008), which
mediate transforming growth factor b (TGF-b)-induced epithe-
lial-to-mesenchymal transition (EMT), i.e., the transdifferentia-
tion of epithelial cells to fibroblasts (Thiery et al., 2009). In addi-
tion, DDX5 and DDX17 control the biogenesis of miRNAs via
their interaction with the Drosha/DGCR8 complex (Fukuda
et al., 2007, Suzuki et al., 2009). Finally, DDX5 and DDX17 are
also components of the spliceosome and regulate alternative
splicing (Dardenne et al., 2012; Germann et al., 2012; Lin et al.,
2005; Samaan et al., 2014).
Two mutually nonexclusive models have been proposed to
explain the role of DDX5 and DDX17 in alternative splicing. First,
DDX5 and DDX17 may modulate splicing decisions owing to
their ability to actively unwind the duplex between the U1 small
nuclear RNA (snRNA) and the 50 splice site (50ss), favoring the
transition from the pre- to active spliceosome (Lin et al., 2005).
Second, DDX5 andDDX17 have been shown in two genemodels
(H-ras and Tau) to impact RNA secondary structures that modu-
late access of the U1 snRNA to the 50ss or access of the RBM4
splicing regulator to its binding site downstream of a weak 50ss
(Camats et al., 2008; Kar et al., 2011). Whether DDX5 and
DDX17 influence a specific class of secondary structure is not
known. However, in both models the RNA helicase activity of
DDX5 and DDX17 is required and the 50ss seems to be the pref-
erential target of these factors. In addition, these models point to
a role of DDX5/DDX17 in controlling the kinetics of splicing by
favoring either the transition between different states of the spli-
ceosome or the recruitment of splicing factors downstream of
the 50ss.
In this report, we demonstrate that DDX5 and DDX17 coop-
erate with heterogeneous nuclear ribonucleoprotein (hnRNP)
H/F splicing regulators at the level of 50ss located in regions
that are prone to form G-quadruplex structures. This coopera-
tion helps to establish specific splicing subprograms in epithe-
lial cells and myoblasts. We next show that the downregulation
of DDX5/DDX17 expression observed during EMT and myogen-
esis contributes to the reprogramming of splicing during these
processes. Importantly, this downregulation is mediated by
specific miRNAs whose biogenesis requires both DDX5 and
DDX17. Finally, we show that DDX5 and DDX17 are required
to initiate EMT and myogenesis as transcriptional coregulators
of SMADs and MyoD, respectively, driving the production
of key secondary differentiation regulators. We propose a
model in which DDX5 and DDX17 directly and dynamically
orchestrate transcription, miRNA, and splicing programs in
cell differentiation.
RESULTS
DDX5 andDDX17Regulate Alternative Splicing of Exons
Exhibiting Specific Features
In order to assess the role of DDX5 and DDX17 in splicing, we
performed a genome-wide study using Affymetrix Human
Exon Arrays on epithelial MCF7 breast cancer cells trans-
fected with small interfering RNAs (siRNAs) targeting both
DDX5 and DDX17 (siDDX5/17) or a control siRNA (Figure 1A).
Among the regulated single cassette exons, 63% (233) were
more skipped and 37% (139) were more included following
DDX5/DDX17 depletion (Figure 1B; Table S1). Hereafter,
‘‘class S’’ and ‘‘class I’’ exons will respectively refer to skipped
and included exons upon DDX5/DDX17 depletion. As shown in
Figures 1C and S1A, there was a good correlation between
Exon Array prediction and extensive RT-PCR validation
(n = 121).
While analyzing DDX5/DDX17-regulated exons by RT-PCR,
we observed that class I exons had a low basal inclusion rate
in control cells (Figures 1C and 1D). We confirmed this observa-
tion by examining the computed inclusion rate of DDX5/DDX17-
regulated exons using gene-normalized exon intensities fromour
microarray data sets (Figure S1B) or by computing their inclusion
rate from the corresponding mRNAs annotated in public libraries
(Figure S1C). The poor inclusion of class I exons is explained by
the fact that they have weak 50ss and 30ss compared with both
constitutive (CONS) and alternative (ALT) exons (Figures 1E
and S1D). These exons are also flanked by large introns
(Figure 1F).
Class S exons have very different features (Figure 1H). First,
they are highly included in control cells (Figures 1C and 1D,
S1B, and S1C). They are flanked by short introns and have strong
30ss (Figures 1F and S1D). In addition, the 50ss of class S exons is
embedded inGC-rich sequences, in contrast to the 50ss of class I
exons (Figure 1G). However, similarly to class I exons, class S
exons harbor weak 50ss (Figure 1E).CDDX5/DDX17 and hnRNPH/F Regulate the Same Subset
of Exons
Because class S exons are highly included in control cells
despite their weak 50ss, we hypothesized that 50ss activators
may enhance their inclusion in a DDX5/DDX17-dependent
manner. To test this hypothesis, we computed the density of pre-
viously reported intronic splicing enhancers (ISE) downstream of
the 50ss regulated by DDX5 and DDX17 (Lim and Burge, 2001;
Zhang et al., 2005). As shown in Figure S1E, there is an enrich-
ment of ISE downstream of class S exons compared with control
sets of alternative and constitutive exons. We then used the
SFmap software (Paz et al., 2010) to search for specific ISE
motifs. Because class S 50ss were embedded in GC-rich
sequences (Figure 1G), we focused our attention on splicing fac-
tors with a known affinity for GC-rich motifs, such as hnRNP H/F
(Huelga et al., 2012; Katz et al., 2010; Xiao et al., 2009). Clearly,
there is an enrichment in hnRNP H/F binding motifs downstream
of class S exons (Figure S1E).
Supporting an important functional connection between
DDX5/DDX17 and hnRNP H/F, an analysis of a previously pub-
lished RNA sequencing (RNA-seq) data set (Xiao et al., 2009)
showed that at least 60 of the 233 class S exons (i.e., skipped
upon DDX5/DDX17 depletion) were also skipped following
hnRNP H1 depletion (Table S2). In addition, analysis of existing
crosslinking immunoprecipitation sequencing (CLIP-seq) data
sets (Huelga et al., 2012; Katz et al., 2010) revealed that those
60 exons, as well as the complete set of 233 class S exons,
are flanked by a larger number of hnRNP H/F CLIP-seq reads
than a control set of randomly selected alternative exons (Fig-
ure 2A; Table S2). Remarkably, joint hnRNP H/F and DDX5/
DDX17 depletion (Figure S1F) cooperatively enhanced the skip-
ping of exons containing hnRNP H/F binding sites, but not of
control exons without hnRNP H/F binding sites (Figures 2B
and 2C).
Intriguingly, while analyzing the environment of class I exons,
we observed that the 50ss of exons (n  1), i.e., located just up-
stream of class I exons (n), present features similar to the 50ss of
class S exons (n): they are embedded in GC-rich sequences
(Figure 2D) and they are enriched in intronic hnRNP H/F binding
sites (Figure 2E). Based on the similar 50ss configuration of
class I exons (n  1) and class S exons (n), and on recent kinetic
models of splicing regulation (Schor et al., 2013), we hypothe-
sized that in the case of class I exons, the depletion of DDX5/
DDX17 and/or hnRNP H/F could slow down splicing of exon
(n  1) to exon (n + 1), and consequently increase the time win-
dow for recognition and inclusion of the weak exon (n). To test
this model, we selected a set of class I exons with or without
hnRNP H/F binding sites downstream of exon (n  1). Remark-
ably, hnRNP H/F depletion, by itself or together with DDX5/
DDX17 depletion, enhanced exon (n) inclusion only when hnRNP
H/F binding sites were present downstream of exon (n  1)
(Figure 2E).
We next reasoned that if DDX5/DDX17 depletion would slow
down exon (n 1) to exon (n + 1) splicing, this would give enough
time for splicing activators to enhanceweak exon (n) inclusion. As
the 50ss of class I exons are followed by GC-poor sequences, we
looked for TIA1 and TIAL1 binding sites because these factors
bind to AT-rich motifs (Wang et al., 2010b; Figure 1F). Analysisell Reports 7, 1900–1913, June 26, 2014 ª2014 The Authors 1901
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of available CLIP-seq data sets revealed an enrichment of TIA1
binding sites downstream of class I exons (Figure 2F; Table S2).
Furthermore, TIA1/TIAL1 depletion (Figure S1G) reduced
DDX5/DDX17-mediated exon inclusion only when TIA1/TIAL1
binding sites were found downstream of the regulated exons,
but not in a control exon (Figure 2G). It must be underlined
that DDX5/DDX17 depletion slightly decreased TIA1 and TIAL1
protein expression levels (Figure S1G). However, the effect of
DDX5/DDX17 depletion on splicing could not be a consequence
of TIA1/TIAL1 downregulation, because in that case the co-
depletion of TIA1/TIAL1 and DDX5/DDX17 would have had
similar effects andnot antagonistic effects as shown in Figure 2G.
Cooperation between DDX5/DDX17 and hnRNP H/F
on G-Quadruplex Structures
It was previously shown that hnRNP H/F binds to G-tracts that
can form G-quadruplexes (Decorsie`re et al., 2011). Interest-
ingly, the high kinetic stability of a G-quadruplex limits hnRNP
H/F binding to G-rich sequences (Samatanga et al., 2013).
Computational analysis revealed an enrichment in predicted
G-quadruplexes downstream of class S exons (n) when
compared with class I exons (n) or a set of control exons (Fig-
ure 3A, right panel). Remarkably, an enrichment in G-quadru-
plexes was also predicted downstream of exons (n  1) of class
I exons compared with class S exons (n  1) or a set of control
exons (Figure 3A, left panel). Therefore, we hypothesized that
the RNA helicase activity of DDX5 and DDX17 may favor the
binding of hnRNP H/F to G-tracts embedded in G-quadruplex
RNA structures.
Several lines of evidence support this hypothesis. First, in
cellulo stabilization of G-quadruplex structures using the
TMPyP4 reagent had the same effect on splicing as the silencing
of DDX5/DDX17 or HNRNPH/F genes (Figure 3B). Second,
hnRNP H1 coimmunoprecipitated with both DDX5 and DDX17
(Figure 3C), in agreement with previous reports that suggested
an interaction between these factors (Camats et al., 2008; Lau-
rent et al., 2012). Such an interaction was further supported by
an in situ proximity-ligation assay (PLA), a sensitive approach
that uses rolling-circle amplification of fluorescent oligonucleo-
tide probes linked to primary antibodies to reveal complexes be-
tween single molecules in close proximity (<40 nm) in cells. PLA
using DDX5 and hnRNPH1 antibodies detectedmultiple spots in
the nuclei of MCF7 cells (Figure 3D), which could reflect either aFigure 1. Genome-Wide Impact of DDX5/DDX17 on Splicing Defines T
(A) Western blot showing the expression of DDX5 and DDX17 in MCF7 cells 48 hr a
and DDX17 (siDDX5/17).
(B) Pie chart showing the number of skipped and included exons following DDX5
(C) RT-PCR validation of splicing events. Class S (skipped in the absence of DDX5
and blue, respectively. The exon number is indicated.
(D) Boxplot representing the percentage of exon inclusion obtained by RT-PCR
(E) Boxplot representing the 50ss strength of class S (S) and class I (I) exons or t
alternative (ALT) exons.
(F) Boxplot representing the average length of introns upstream and downstream
(G) Boxplot representing the percentage of G/C nucleotides within the 30-nt-lon
(H) Schematic representation of DDX5/DDX17-regulated exon features. The skipp
GC-rich region. The included exons (n in blue) have aweak 50ss (50w), a weak 30ss (
are smaller than the introns surrounding included exons. **p < 0.01, ***p < 0.001
See also Figure S1 and Table S1.
Cdirect interaction or the close proximity of the two proteins
bridged by RNA molecules. Third, an antibody against hnRNP
H1 (but not a control antibody) immunoprecipitated their target
RNAs, and DDX5/DDX17 depletion reduced this interaction
(Figure 3E).
Finally, the helicase activity of DDX5 and DDX17 was
required for the regulation of both exon inclusion and skipping.
Stable inducible MCF7 cells were transfected with siRNAs tar-
geting the UTR (50 or 30) of endogenous DDX5 and DDX17
mRNAs (siDDX5/17-UTR), which had the same effect as
siDDX5/17 (compare, for example, Figures 1C and 3F). Reex-
pression of wild-type DDX5 (Samaan et al., 2014) rescued the
splicing pattern of the tested exons to a level close or identical
to the control level (Figure 3F, lanes 1–3). In contrast, expres-
sion of a DDX5 mutant (DDX5-KA) lacking the helicase activity
could not restore, or only partially restored, the splicing of
the tested exons (Figure 3F, lanes 4–6). Similar results
were obtained with DDX17 (Figure S1H), underlining the func-
tional redundancy between the two proteins in splicing
regulation.
Cooperation between DDX5/DDX17 and hnRNP H/F
Contributes to Establish Epithelial- and Myoblast-
Specific Splicing Programs
To confirm the cooperation between DDX5/DDX17 and hnRNP
H/F in a different context, we performed a genome-wide analysis
using Affymetrix Exon Arrays after DDX5/DDX17 depletion in
MCF10A cells, another epithelial breast cell line (Figures 4A
and S2A; Table S3). Remarkably, the DDX5/DDX17-regulated
exons in MCF10A cells presented similar characteristics
compared with DDX5/DDX17-regulated exons in MCF7 cells
(Figures S2B–S2D). In addition, a subset of DDX5/DDX17-
controlled exons were regulated by a cooperation between
these RNA helicases and hnRNP H/F in MCF10A cells, as
observed in MCF7 cells (Figure 4B). Finally, the in situ PLA
confirmed the interaction between DDX5 and hnRNP H1 in
MCF10A cells (Figure S2E).
MCF10A epithelial cells are particularly interesting because
they can undergo EMT upon TGF-b treatment, a process that
may involve DDX5, which has been shown to interact with
SMAD proteins (Figure S3A) (Warner et al., 2004), the mediators
of the cell response to TGF-b. Interestingly, we noticed that
TGF-b treatment of MCF10A cells induced a decrease of DDX5wo Classes of Regulated Exons
fter transfection with a control siRNA () or with an siRNA targeting bothDDX5
/DDX17 depletion.
/DDX17) and class I (included in the absence of DDX5/DDX17) exons are in red
in control (siCTRL) and siDDX5/17 conditions.
he total of both classes (S+I), as well as control sets of constitutive (CONS) or
of the indicated exons (defined as in E).
g region downstream of the 50ss of the indicated exons (as in E).
ed exons (n in red) have a weak 50ss (50w), a strong 30ss (30s), and a downstream
30w), and a downstreamAT-rich region. The introns surrounding skipped exons
; Wilcoxon rank sum test.
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Figure 2. The Localization of GC-Rich hnRNPH/FBinding Sites Defines the SplicingOutcomeof the TwoClasses of DDX5/DDX17-Regulated
Exons
(A) A 100% stacked bar chart representing the percentage of exons with hnRNP H1/F CLIP-seq reads. Three classes of exons were defined: a subset of
experimentally validated 60 hnRNP H1-dependent class S exons (skipped H1), the total pool of class S exons (class S), and a panel of 985 alternative exons
(Control). The distribution of the number of reads within regions of 500 nt upstream and/or downstream of tested exons was classified into three groups: no read
(0), one to 10 reads, and more than 10 reads localized (***p < 0.001, c2 test).
(B) RT-PCR analysis of the effect of DDX5/DDX17 and/or hnRNP H/F depletion on class S exons enriched in hnRNP H1/F binding sites. PCR gels are repre-
sentative of three independent experiments. Quantification is shown as the percentage of alternative sequence inclusion (psi).
(legend continued on next page)
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and DDX17 protein expression levels (Figure 4C). This prompted
us to investigate the function of DDX5 and DDX17 during this
process.
The decreased expression of DDX5/DDX17 led us to hypoth-
esize that some alternative exons might be similarly affected
by TGF-b treatment and siRNA-mediated DDX5/DDX17
silencing. To test this hypothesis, we analyzed the effect of
siDDX5/DDX17, in the absence of TGF-b treatment, on the inclu-
sion of a set of exons previously reported to be regulated during
EMT (Shapiro et al., 2011; Warzecha et al., 2010). Remarkably, a
number of TGF-b-regulated exons were regulated similarly by
DDX5/DDX17 depletion in untreated MCF10A cells (Figure 4D).
Because some of these exons were also regulated in the same
manner by hnRNP H/F depletion in the absence of TGF-b (Fig-
ure 4E), we concluded that the cooperation between DDX5/
DDX17 and hnRNPH/F contributes tomaintain an epithelial-spe-
cific splicing pattern and that DDX5/DDX17 downregulation dur-
ing EMT contributes to switch splicing toward a fibroblast-like
splicing program.
Based on a previous report (Caretti et al., 2006), we also
investigated the role of Ddx5/Ddx17 in myogenesis using the
well-studied mouse C2C12 myoblast cells. Strikingly, just as
we found during TGF-b-mediated EMT, we observed a
decreased expression of both Ddx5 and Ddx17 proteins upon
induction of myoblast differentiation (Figure 4F). In a remarkable
parallel to what we observed in MCF10A cells, a subset of
exons that are regulated during differentiation of C2C12 cells
(Bland et al., 2010) were regulated in the same manner upon
Ddx5/Ddx17 silencing in undifferentiated myoblasts (Figures
4G and S3B). Interestingly, more than half of these exons
were also coregulated by hnRNP H/F (Figure 4G, right panel).
Importantly, and as observed in MCF7 and MCF10A cells,
Ddx5 and hnRNP H1 interacted directly in C2C12 cells (Figures
S3C and S3D).
Altogether, these results support a model in which the cooper-
ation between DDX5/DDX17 and hnRNP H/F helps to define
epithelial- and myoblast-specific splicing subprograms. DDX5
and DDX17 downregulation may therefore contribute to the
splicing changes that occur during EMT and myogenesis.
The Downregulation of DDX5 and DDX17 Is Part of a
Feedback Regulatory Loop Involving miRNAs
Because the downregulation of DDX5 and DDX17 during EMT
andmyogenesis may appear contradictory to their previously re-
ported function in these processes (Caretti et al., 2006; Yang
et al., 2006), we sought to investigate the molecular mechanism(C) Effect of hnRNP H/F on control class S exons without any CLIP-seq read.
(D) Upper panel: schematic representation of class I exons (n) with their upstream
%GC within 30 nt upstream or downstream of splice sites. Lower panel: boxplot
values for class S exon (n) and class I exons (n  1) are circled in red and blue, r
(E) Top-left panel: percentage of hnRNP H1/F CLIP-seq reads downstream of cla
hnRNP H/F depletion on class I exons harboring hnRNP H1/F CLIP-seq reads do
CLIP-seq read).
(F) A 100% stacked bar chart representing the percentage of TIA1/TIAL1 CLIP-seq
Details as in (A).
(G) Left panel: RT-PCR analysis of the effect of TIA1/TIAL depletion on class I exon
(no CLIP-seq read).
See also Figures S1F and S1G, and Table S2.
Cthat causes this downregulation. Interestingly, phylogenetically
conserved binding sites for two miRNAs known to be upregu-
lated during myogenesis, miR-1 and miR-206 (Rao et al.,
2006), were predicted within the 30 UTR of both DDX5 and
DDX17 mRNAs (Figures S4A and S4B). Strikingly, overexpres-
sion of pre-miR-1 or pre-miR-206 in C2C12 cells reduced
Ddx5 and Ddx17 protein levels (Figure 5A). Luciferase assays
confirmed that this effect was mediated by a direct binding of
miR-1/206 onto the predicted sites in mouse Ddx5 and Ddx17
30 UTRs (Figure 5B).
Induction of miR-1 and miR-206 expression during myogene-
sis is mediated at least in part by MyoD (Rao et al., 2006), which
is coregulated by Ddx5 and Ddx17 (Caretti et al., 2006; Fig-
ure S5A). Remarkably, the induction of mature miR-1 and miR-
206 during differentiation of C2C12 cells was prevented by
Ddx5/Ddx17 depletion (Figure 5C, yellow). We observed a
similar inhibition when we looked at the miRNA precursors pri-
miR-1a1 and pri-miR-206 (Figure 5C, orange), indicating that
the primary effect was a transcriptional inhibition of thesemiRNA
genes. However, the partial repression of pri-miR-206 induction
upon Ddx5/Ddx17 silencing could also reflect an effect on the
processing of miR-206 precursors, in agreement with previous
reports (Fukuda et al., 2007; Suzuki et al., 2009; Hong et al.,
2013). Yet, a direct transcriptional effect was strongly supported
by the recruitment of Ddx5 to the promoters of both miR-1 and
miR-206 coding genes (Figure 5D).
Several lines of evidence supported a similar feedback loop in
MCF10A cells. First, the DDX5 30 UTR contains two predicted
binding sites for miR-181b (Figure S4A), which is known to be
induced by TGF-b treatment (Wang et al., 2010a). Overexpres-
sion of pre-miR-181b inMCF10A cells reduced the DDX5 protein
level (Figure 5E), and luciferase assays confirmed that this effect
was mediated by a direct binding of miR-181b to the DDX5 30
UTR, at least on the most conserved of the predicted sites (Fig-
ures 5F and S4A). Intriguingly, miR-181b also repressed endog-
enous DDX17 expression (Figure 5E), even though no miR-181b
binding site was predicted within DDX17 30 UTR (Figure S4B).
This suggested either the existence of a noncanonical and/or
nonpredicted binding site or an indirect regulation of DDX17
expression by miR-181b. Second, the TGF-b-induced expres-
sion of miR-181b in MCF10A cells was dependent on SMAD
transcription factors (Figures S5B and S5C), which interact
with DDX5 as described above (Figure S3A). As expected,
TGF-b-induced miR-181b and pri-miR-181b expression was
prevented by DDX5/DDX17 depletion (Figure 5G) and DDX5
was recruited on the promoter of the miR-181b-1 gene promoter(n 1) and downstream (n + 1) exons. The numbers correspond to the median
as in Figure 1G, except that it also includes class I exons (n  1). The median
espectively.
ss I or control exons (n  1). Details as described in (A). Right panel: effect of
wnstream of their exon (n  1). Bottom-left panel (framed): negative control (no
reads in a region of 700 nt downstream of class I exons (n) or control exons (n).
s (n) containing TIA1/TIAL binding sites. Right panel (framed): negative controls
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Figure 3. DDX5, DDX17, and hnRNP H/F Cooperate on G-Quadruplex Structures
(A) Prediction of G-quadruplex structures downstream of 50ss of exons (n 1) and (n) of class S (red line), class I (blue line), or control (black line) exons. Results of
the predictions are schematized under the graphs.
(B) Splicing of alternative exons in MCF7 cells treated or not with TMPyP4 (left panel), or treated with siDDX5/17 and/or siHNRNPH/F (as in Figure 2).
(C) Western blot analysis of hnRNP H1 after IP of cell lysates from stably induced (+ Dox) HA-DDX5 or FLAG-DDX17 MCF7 cell lines with HA (left) or FLAG (right)
antibodies. Inputs (IN) correspond to 10% of total extract.
(D) In situ PLA showing the interaction between hnRNP H1 and DDX5 in the nuclei (stained with Hoechst) of MCF7 cells treated with control siRNA or siDDX5/17.
(E) qRT-PCR analysis after transfection with control siRNA (siCTRL) or siDDX5/17, and RNA-IP using control IgG antibody or hnRNP H1 antibodies. Amplification
was performed with primers (arrows) encompassing the 50ss of class S exon (n) or class I exon (n  1) of the indicated genes. The results, calculated as the
(legend continued on next page)
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(Figure 5H), demonstrating a direct role of DDX5 in miR-181b
induction.
Our results revealed that DDX5 and DDX17 directly promote
the expression of differentiation-specific miRNAs that in turn
directly downregulate their expression. Supporting a model in
which miRNA-mediated DDX5/DDX17 downregulation drives a
specific splicing program, ectopic overexpression of miR-1 or
miR-206 in C2C12 cells, or miR-181b in MCF10A cells induced
a splicing pattern similar to that observed after cell differentiation
and DDX5/DDX17 depletion (compare Figures 4G and 5I with
Figures 4D and 5J).
DDX5 and DDX17 Directly Control the Transcriptional
Activation of Secondary Master Transcription Factors
of Cell Differentiation
Although the expression of DDX5 and DDX17 is downregulated
during EMT and myogenesis, their presence is required for early
steps of cell differentiation. In addition to their role in regulating
the production of differentiation-specific miRNAs, we found
that, in line with previous observations (Caretti et al., 2006),
Ddx5/Ddx17 knockdown in C2C12 cells also inhibited the
MyoD-dependent expression of Myog and Mef2c, two master
myogenic regulators (Figure 6A). This effect was most likely
direct, since Ddx5 was recruited on the promoters of Myog
and Mef2c genes (Figure 6A, right). As expected, Ddx5/Ddx17
depletion compromised the formation of myotubes (Figure 6B),
confirming their key function in myogenesis.
Likewise, DDX5/DDX17 knockdown prior to TGF-b treatment
inhibited, at both RNA and protein levels, the TGF-b-induced
and SMAD2/3-dependent expression of SNAI1 and SNAI2, two
master regulators of EMT (Thiery et al., 2009; Figures 6C and
S6A). This effect was direct, as DDX5 was recruited on SNAI1
and SNAI2 promoters (Figure 6C, right), along with SMAD4 (Fig-
ure S6B). As expected, SNAIL1/2-target genes were not properly
regulated by TGF-b in DDX5/DDX17-depleted cells. This
included genes coding for proteins involved in epithelial cell junc-
tions, such as Occludin and E-Cadherin (Figures S6C and S6D).
As a consequence, the SNAIL-dependent loss of epithelial cell
junctions, which is normally induced by TGF-b (Cano et al.,
2000), and the expression of mesenchymal markers (e.g., FAP)
were compromised in DDX5/DDX17-depleted cells (Figures
6D, S6C, and S6E). Thus, DDX5 and DDX17 serve as key tran-
scriptional coregulators of SMADs in mediating the induction
of EMT by TGF-b.
Collectively, these results support a model in which DDX5 and
DDX17 cooperate with hnRNP H/F to express a specific splicing
subprogram in epithelial cells andmyoblasts, and are required to
initiate differentiation as transcriptional coregulators of MyoD
and SMAD transcription factors (Figure 7). As a consequence,
they contribute to the initiation of a differentiation-specific tran-
scription program and elicit the biogenesis of specific miRNAs,percentage of input RNA, are represented as the mean values of at least three ind
presence of control siRNA), which was arbitrarily set to 1 ± SD (paired Student’s
(F) Splicing rescue experiments. Stable MCF7 cells were transfected with siDDX
DDX5 or the RNA helicase mutant DDX5-KA. One representative experiment is s
control sample.
See also Figure S1H.
Ctriggering a feedback control loop that contributes to the switch-
ing of splicing programs during differentiation.
DISCUSSION
Understanding alternative splicing regulation during cell differen-
tiation is a major challenge because different cell types express
different splicing isoforms that contribute to cell-specific func-
tions (Merkin et al., 2012; Mallinjoud et al., 2014). Although the
primary sequence elements of pre-mRNAs that contribute to
alternative splicing are increasingly being characterized, the
contribution of secondary RNA structures is far less understood
(Jin et al., 2011). In this report, we propose a model in which the
RNA helicase activity of DDX5 and DDX17 favors the binding of
hnRNP H/F to G-tracts that can form G-quadruplex structures
and assist them in their splicing-enhancer function. Supporting
this model, the enhancer function of hnRNP H/F has been linked
to G-runs positioned downstream of 50ss (Wang et al., 2012b;
Wang and Cambi, 2009; Xiao et al., 2009). Remarkably, if
DDX5/DDX17 help the recruitment of hnRNP H/F downstream
of an alternative exon defined by a weak 50ss (class S), they
enhance exon inclusion (Figure 1H) and their depletion results
in exon skipping (Figures 2A–2C). However, if DDX5/DDX17
and hnRNP H/F cooperate at the level of an upstream exon
(n  1), this results in the skipping of the downstream weak
exon (class I; Figure 1H). In this case, depletion of DDX5/
DDX17 and/or hnRNPH/F favors the inclusion of theweak down-
stream exon (Figures 2D and 2E). This effect is in agreement with
recent kinetic models of splicing regulation (Schor et al., 2013).
Indeed, if splicing between two exons is efficient, weak internal
exons are skipped and are recognized only when the splicing
process is slowed down. Supporting this model, depletion of
TIA1/TIAL1 splicing activators, which act downstream of weak
exons (Wang et al., 2010b), inhibited the exon inclusion pattern
induced by DDX5/DDX17 depletion (Figures 2F and 2G).
Our data indicate that the cooperation between DDX5/DDX17
and hnRNP H/F helps to maintain epithelial- and myoblast-spe-
cific splicing subprograms, as some of the exons that are regu-
lated during EMT andmyoblast differentiation are under the con-
trol of these factors (Figure4). In this context, itmustbeunderlined
that exons regulated during EMT are flanked by hnRNPH/F bind-
ingmotifs (Shapiroet al., 2011) and that a functionof hnRNPH/F in
muscle cells has previously been reported (Chen et al., 1999; Paul
et al., 2011). Since DDX5 and DDX17 contribute to maintain
epithelial- and myoblast-specific splicing subprograms, their
downregulationduringEMTandmyogenesismay favor theswitch
toward the previously reported fibroblast- and myotube-specific
splicing programs (Bland et al., 2010; Shapiro et al., 2011). Even
though there is a strong overlap between DDX5/DDX17- and
hnRNP H/F-regulated exons, as we observed that at least 159
of the 372 DDX5/DDX17-regulated exons in MCF7 cells areependent experiments (nR 3) and normalized to the control sample (IP in the
t test: *p < 0.05).
5/17-UTR and treated with doxycycline to induce the expression of wild-type
hown (n = 3). Quantification is shown as the fold change of psi relative to the
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Figure 4. DDX5/DDX17 and hnRNP H/F Control the Splicing of a Subset of Exons in Epithelial Cells and Myoblasts
(A) Diagram showing the number of skipped (class S, red) and included (class I, blue) exons upon silencing of DDX5 and DDX17 in MCF10A cells.
(B) RT-PCR analysis of the effect of DDX5/DDX17 and hnRNP H/F on the splicing of a subset of alternative exons in MCF10A cells.
(C) Expression of DDX5 and DDX17 in TGF-b-treated MCF10A cells. Actin: loading control.
(D) Splicing of alternative exons in MCF10A cells treated with TGF-b or siDDX5/17. Quantification is shown as the fold change of psi relative to the control sample.
(E) Effect of hnRNP H/F on the splicing of TGF-b-induced and DDX5/DDX17-regulated exons.
(F) Expression of Ddx5 and Ddx17 during a time-course differentiation of C2C12 cells. Actin: loading control.
(G) Splicing of alternative exons in C2C12 cells induced to differentiate (left panel) or treated with siDdx5/17 (right panel). The black line separates exons that are
coregulated or not by hnRNP H/F. Quantification as in (D). *The two upper bands were quantified together as included forms.
See also Figures S2 and S3, and Table S3.
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Figure 5. A Negative Feedback Loop Involving miRNAs Regulates DDX5/DDX17 Expression during Differentiation
(A) Expression of Ddx5 and Ddx17 in C2C12 cells overexpressing pre-miR-1, pre-miR-206, or a control pre-miR.
(B) Luciferase assays measuring the effect of miR-1 or miR-206 on wild-type and mutated mouse Ddx5 and Ddx17 30 UTR.
(C) Expression of miR-1 (top panel) and miR-206 (bottom panel) in C2C12 cells. Mature miRNA (yellow) or pri-miRNA (orange) were quantified 24 hr after dif-
ferentiation of cells pretreated with control siRNA or siDdx5/17. Values were normalized to undifferentiated cells.
(D) ChIP experiment showing Ddx5 binding to mmu-miR-1a-1 (top) and mmu-miR-206 (bottom) promoters.
(E) Expression of DDX5 and DDX17 in TGF-b-treated MCF10A cells overexpressing pre-miR-181b or a control pre-miRNA.
(F) Luciferase assays measuring the effect of miR-181b on wild-type and mutated human DDX5 30 UTR. Details are as described in (B).
(G) Expression of mature miR-181b (light blue) and pri-miR-181b (dark blue) in MCF10A cells treated or not with TGF-b for 24 hr. Details as in (C).
(H) ChIP experiment showing DDX5 binding to the miR-181b promoter in MCF10A cells after 2 hr of TGF-b treatment.
(I) Alternative splicing in C2C12 cells ectopically expressing miR-1 or miR-206.
(J) Alternative splicing in MCF10A cells treated or not with TGF-b for 24 hr. Histograms represent a mean of at least three independent experiments ± SD (ChIP:
technical qPCR replicates of one representative experiment out of three carried out independently). Student’s t test: *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figures S4 and S5.similarly regulated by hnRNPH/F and/or contain hnRNPH/FCLIP
sequences (Figures1and2; TableS2),DDX5/DDX17could havea
wide impact on alternative splicing during EMT and myogenesis
by modulating the activity of several other splicing factors. For
example, DDX5 and DDX17 have been shown to work with
RBM4andMBNL,which are involved in thecontrol ofmyogenesis
(Kar et al., 2011; Laurent et al., 2012; Lin and Tarn, 2011).CInterestingly, one of the main phenotypes observed in both
epithelial and myoblast cells under DDX5/DDX17 depletion
was the formation of lamellipodia (Figure S7A; movies are also
viewable on our website, https://fasterdb.lyon.unicancer.fr/
dardenne/), which characterize motile mesenchymal cells and
contribute to the alignment and fusion of myoblasts. Several
genes that were spliced similarly upon DDX5/DDX17ell Reports 7, 1900–1913, June 26, 2014 ª2014 The Authors 1909
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Figure 6. DDX5 and DDX17 Control the Expression of Master Transcriptional Regulators of EMT and Myogenesis
(A) qRT-PCR analysis of Myog and Mef2c in C2C12 cells after treatment with control siRNA, siMyod, or siDdx5/17, followed by incubation in growth ( Diff) or
differentiation (Diff) medium. Right panel: ChIP experiment showing Ddx5 binding to Myog and Mef2c promoters in differentiating C2C12 cells.
(B) Immunolabeling of C2C12 cells with an anti-myosin heavy chain (MHC) antibody. Scale bar, 20 mm.
(C) qRT-PCR analysis of SNAI1 and SNAI2 in MCF10A cells after treatment with control siRNA, siSMAD2/3, or siDDX5/17, followed or not by a 24 hr treatment
with TGF-b. Right panel: ChIP experiment showing DDX5 binding to SNAI1 and SNAI2 promoters in MCF10A after 2 hr of TGF-b treatment. Histograms in (A) and
(C) represent the mean values of at least three independent experiments normalized to the control sample ± SD (Student’s t test: *p < 0.05, **p < 0.01).
(D) Immunolabeling of MCF10A cell junctions with an anti-E-cadherin antibody. Scale bar, 20 mm.
See also Figure S6.downregulation and during EMT or myoblast differentiation are
involved in actin cytoskeleton dynamics (Figure S7B), a process
that is closely linked to lamellipodia formation. This suggests that
splicing changes elicited by DDX5/DDX17 downregulation
participate in this phenotypic change. However, other mecha-
nisms are likely involved, as DDX5 controls, for example, the
expression of miR-182, which directly affects the reorganization
of the actin cytoskeleton (Wang et al., 2012a).
Finally, our data demonstrate that DDX5 and DDX17 are
required not only for maintaining epithelial- and myoblast-
specific splicing programs but also for initiating EMT and myo-
genesis owing to their role in transcription. Indeed, in agreement
with previous reports (Caretti et al., 2006;Warner et al., 2004), we
demonstrate that DDX5/DDX17 are transcriptional coregulators
of the MyoD and SMAD transcription factors that drive transcrip-
tion programs duringmyogenesis and TGF-b-induced EMT. One
consequence of this cooperation is the production of differenti-
ation-specific miRNAs that in turn decrease the expression
of DDX5/DDX17 (Figure 5). Interestingly, our data indicate that
in addition to playing a role in miRNA processing, as previously
reported (Suzuki et al., 2009; Hong et al., 2013), DDX5 and
DDX17 control miRNA production at the transcriptional level
(Figure 5).1910 Cell Reports 7, 1900–1913, June 26, 2014 ª2014 The AuthorsAltogether, our results confirmed the previously reported
various regulatory functions of the RNA helicases DDX5 and
DDX17 in transcription, splicing, and miRNA biogenesis (Fuller-
Pace and Moore, 2011; Janknecht, 2010). However, our work
unraveled a direct and dynamic orchestration of those gene-
expression layers by DDX5 andDDX17 during cell differentiation.
The DDX5/DDX17-dependent genetic circuitries that we charac-
terized in two different species and biological processes are
remarkably similar (Figure 7), and we propose to define such fac-
tors as master orchestrators of differentiation. It will be inter-
esting to determine whether other DEAD box RNA helicases
that are closely related to DDX5/DDX17 (such as DDX3X,
DDX4/VASA, and DHX9/RHA) and also regulate different levels
of gene expression in a variety of biological processes (Linder
and Jankowsky, 2011) may have such a broad function in coor-
dinating the genetic programs that unfold during biological tran-
sitions or cell differentiation processes.EXPERIMENTAL PROCEDURES
Cell Culture, Treatment, and Transfection
Cell culture of standard and stableMCF7 cells, as well as transient transfection
assays in all cell lines, was performed essentially as described previously
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Figure 7. Orchestrated Regulation of Gene
Expression by DDX5 and DDX17 during
Cell Differentiation
The top (orange) and bottom (green) schemes
represent the differentiation of C2C12 cells into
myotubes and the TGF-b-induced EMTofMCF10A
cells, respectively. Inmyoblasts and epithelial cells,
DDX5 and DDX17 cooperate with hnRNP H/F to
control the splicing of a specific subset of exons.
Upon induction of differentiation, DDX5 andDDX17
coregulate MyoD- or SMAD-dependent transcrip-
tional activity, directly controlling key effectors of
differentiation, includingmiRNAs that in turndirectly
repress the expressionof bothhelicases.DDX5and
DDX17 downregulation contributes to cell-specific
variations in the alternative splicing program and to
phenotypic changes that occur during differentia-
tion, such as the formation of lamellipodia.
See also Figure S7.(Dardenne et al., 2012; Samaan et al., 2014). Details regarding the culture of
C2C12 and MCF10A cells are given in Supplemental Experimental Proce-
dures. Sequences of the siRNAs are provided in Table S4. Pre-miRNA Precur-
sors (Life Technologies) were used at a final concentration of 10 nM. For the
analysis of the impact of potential G-quadruplexes on splicing, MCF7 cells
were treated for 48 hr with 150 mM TMPyP4, a molecule that stabilizes
G-quadruplexes.
Luciferase Assays
Luciferase assays using DDX5 or DDX17 reporters cloned in the psiCHEK-2
plasmid (Promega) were carried out using the Dual-Luciferase Reporter Assay
System (Promega) as detailed in Supplemental Experimental Procedures.
RNA Analysis
RNA extraction, RT-PCR, and quantitative RT-PCR (qRT-PCR) were per-
formed as described previously (Dardenne et al., 2012; Samaan et al., 2014).
The primer sequences for PCR and qPCR are provided in Table S4. Quantifi-
cation of mature miRNAs was carried out using the miRCURY LNA Universal
cDNA synthesis and SYBR Green PCR kit (Exiqon), with specific LNA primer
sets, according to the manufacturer’s instructions. qRT-PCR values were
normalized relative to U6 snRNA.
Chromatin and RNA Immunoprecipitation
Chromatin immunoprecipitations (ChIPs) were performed as previously
described (Fattet et al., 2013; Zonta et al., 2013) using antibodies against
DDX5 (4 mg, A300-523A; Bethyl), SMAD4 (sc-7154; Santa Cruz), or control
immunoglobulin G (IgG, sc-2027; Santa Cruz). RNA-IP was performed as pre-
viously described (Bittencourt et al., 2008) using hnRNP H1 antibodies (A300-
511A; Bethyl) or rabbit IgG (sc-2027; Santa Cruz).
Microscopy
Details regarding the protocols used for immunofluorescence, in situ PLAs,
and time-lapse videomicroscopy are given in Supplemental Experimental
Procedures.
Bioinformatics
Microarray analyses were performed as described previously (Mallinjoud et al.,
2014). Exon numbering of mouse and human genes was based on the
FasterDB annotation (https://fasterdb.lyon.unicancer.fr/index.php).
MaxEntScan was used to measure the scores of the 50ss and 30ss. SFmap
web server (http://sfmap.technion.ac.il/) (Paz et al., 2010) was used to predict
and map known splicing-factor binding sites. The UCSC LiftOver tool (http://
genome.ucsc.edu/cgi-bin/hgLiftOver) was used to look at conservation be-
tween human and mouse exons.
Publicly available CLIP-seq data sets were retrieved from the NCBI
Gene Expression Omnibus for hnRNPH1 and hnRNPF (GSE23694 andCGSE34993), and from ArrayExpress for TIA and TIAL1 (E-MTAB-432). The
number of reads that overlapped the regions of interest was computed using
coverageBed (Bedtools).
For the prediction of G-quadruplex structures, the first 50 or 60 intronic nu-
cleotides downstream of the exons of interest were searched for the previously
described alternative G-quadruplex motif Gn > 2-(N1-7-Gn > 2)3 (Xiao et al.,
2013). Each sequence position was associated to the number of G-quadru-
plexes that overlap this nucleotide. The data points were then binned to
smooth the curve (bin size set to 5).
ACCESSION NUMBERS
The raw microarray data for the DDX5/DDX17 silencing experiments per-
formed in MCF7 and MCF10A cells have been deposited in the NCBI Gene
Expression Omnibus under accession number GSE57281.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.05.010.
AUTHOR CONTRIBUTIONS
E.D. performed experiments and analyzed data. M.P.E. performed experi-
ments and bioinformatic analyses, and analyzed data. L.F., S.G., M.-P.L.,
H.N., E.Z., L.G., M. Deygas, F.Z.C., and S.S. performed experiments and
analyzed data. H.M., F.-O.D., and L.-C.T. performed bioinformatic analyses.
R.R. designed experiments and analyzed data. M. Dutertre analyzed data
and edited the paper. C.F.B. designed and performed experiments, analyzed
data, and co-wrote the paper. D.A. designed experiments, analyzed data, and
co-wrote the paper. All authors gave input on the paper.
ACKNOWLEDGMENTS
Weare grateful toD. Furling and J.Marie for their comments on themanuscript.
We thank C. Vanbelle and C. Bouchardon (CIQLE-SFR Sante´ Lyon-Est) and
Dr. Joe¨l Lachuer (ProfileXpert-LCMT Facility, Lyon, France) for their assistance
with imaging and microarray analyses, respectively. This work was supported
by grants from INSERM ‘‘Plan Cancer 2009-2013,’’ INCa, the Fondation pour la
Recherche Me´dicale (FRM) and LNCC, and AFM-Te´le´thon. It was also sup-
portedbydoctoral fellowships from theLNCC (E.D.), AFM (M.P.E.), FrenchMin-
iste`re de l’Enseignement Supe´rieur et de la Recherche (L.F. and M.D.), and
FRM (E.Z.), and postdoctoral fellowships from the Centre Le´on Be´rard (H.N.),
FRM (H.M.), and Fondation ARC (S.G., M.P.L., F.Z.C., F.-O.D., and L.-C.T.).ell Reports 7, 1900–1913, June 26, 2014 ª2014 The Authors 1911
Received: October 25, 2013
Revised: April 8, 2014
Accepted: May 5, 2014
Published: June 5, 2014REFERENCES
Bittencourt, D., Dutertre, M., Sanchez, G., Barbier, J., Gratadou, L., and Au-
boeuf, D. (2008). Cotranscriptional splicing potentiates the mRNA production
from a subset of estradiol-stimulated genes. Mol. Cell. Biol. 28, 5811–5824.
Bland, C.S., Wang, E.T., Vu, A., David, M.P., Castle, J.C., Johnson, J.M.,
Burge, C.B., and Cooper, T.A. (2010). Global regulation of alternative splicing
during myogenic differentiation. Nucleic Acids Res. 38, 7651–7664.
Camats, M., Guil, S., Kokolo, M., and Bach-Elias, M. (2008). P68 RNA helicase
(DDX5) alters activity of cis- and trans-acting factors of the alternative splicing
of H-Ras. PLoS ONE 3, e2926.
Cano, A., Pe´rez-Moreno, M.A., Rodrigo, I., Locascio, A., Blanco, M.J., del Bar-
rio, M.G., Portillo, F., and Nieto, M.A. (2000). The transcription factor snail con-
trols epithelial-mesenchymal transitions by repressing E-cadherin expression.
Nat. Cell Biol. 2, 76–83.
Caretti, G., Schiltz, R.L., Dilworth, F.J., Di Padova, M., Zhao, P., Ogryzko, V.,
Fuller-Pace, F.V., Hoffman, E.P., Tapscott, S.J., and Sartorelli, V. (2006). The
RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of
MyoD and skeletal muscle differentiation. Dev. Cell 11, 547–560.
Chen, C.D., Kobayashi, R., and Helfman, D.M. (1999). Binding of hnRNP H to
an exonic splicing silencer is involved in the regulation of alternative splicing of
the rat beta-tropomyosin gene. Genes Dev. 13, 593–606.
Dardenne, E., Pierredon, S., Driouch, K., Gratadou, L., Lacroix-Triki, M., Espi-
noza, M.P., Zonta, E., Germann, S., Mortada, H., Villemin, J.P., et al. (2012).
Splicing switch of an epigenetic regulator by RNA helicases promotes
tumor-cell invasiveness. Nat. Struct. Mol. Biol. 19, 1139–1146.
Davis, B.N., Hilyard, A.C., Lagna, G., and Hata, A. (2008). SMAD proteins con-
trol DROSHA-mediated microRNA maturation. Nature 454, 56–61.
Decorsie`re, A., Cayrel, A., Vagner, S., and Millevoi, S. (2011). Essential role for
the interaction between hnRNP H/F and a G quadruplex in maintaining p53
pre-mRNA 30-end processing and function during DNA damage. Genes Dev.
25, 220–225.
Ebert, M.S., and Sharp, P.A. (2012). Roles for microRNAs in conferring robust-
ness to biological processes. Cell 149, 515–524.
Fattet, L., Ay, A.S., Bonneau, B., Jallades, L., Mikaelian, I., Treilleux, I., Gillet,
G., Hesling, C., and Rimokh, R. (2013). TIF1g requires sumoylation to exert
its repressive activity on TGFb signaling. J. Cell Sci. 126, 3713–3723.
Fukuda, T., Yamagata, K., Fujiyama, S., Matsumoto, T., Koshida, I., Yoshi-
mura, K., Mihara, M., Naitou, M., Endoh, H., Nakamura, T., et al. (2007).
DEAD-box RNA helicase subunits of the Drosha complex are required for pro-
cessing of rRNA and a subset of microRNAs. Nat. Cell Biol. 9, 604–611.
Fuller-Pace, F.V., and Moore, H.C. (2011). RNA helicases p68 and p72: multi-
functional proteins with important implications for cancer development. Future
Oncol. 7, 239–251.
Germann, S., Gratadou, L., Zonta, E., Dardenne, E., Gaudineau, B., Fouge`re,
M., Samaan, S., Dutertre, M., Jauliac, S., and Auboeuf, D. (2012). Dual role of
the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 tran-
scription factor. Oncogene 31, 4536–4549.
Hong, S., Noh, H., Chen, H., Padia, R., Pan, Z.K., Su, S.B., Jing, Q., Ding, H.F.,
andHuang, S. (2013). Signaling by p38MAPK stimulates nuclear localization of
the microprocessor component p68 for processing of selected primary micro-
RNAs. Sci. Signal. 6, ra16.
Huelga, S.C., Vu, A.Q., Arnold, J.D., Liang, T.Y., Liu, P.P., Yan, B.Y., Donohue,
J.P., Shiue, L., Hoon, S., Brenner, S., et al. (2012). Integrative genome-wide
analysis reveals cooperative regulation of alternative splicing by hnRNP pro-
teins. Cell Reports 1, 167–178.1912 Cell Reports 7, 1900–1913, June 26, 2014 ª2014 The AuthorsJanknecht, R. (2010). Multi-talented DEAD-box proteins and potential tumor
promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase
(DDX17). Am. J. Transl. Res. 2, 223–234.
Jin, Y., Yang, Y., and Zhang, P. (2011). New insights into RNA secondary struc-
ture in the alternative splicing of pre-mRNAs. RNA Biol. 8, 450–457.
Kalsotra, A., and Cooper, T.A. (2011). Functional consequences of develop-
mentally regulated alternative splicing. Nat. Rev. Genet. 12, 715–729.
Kar, A., Fushimi, K., Zhou, X., Ray, P., Shi, C., Chen, X., Liu, Z., Chen, S., and
Wu, J.Y. (2011). RNA helicase p68 (DDX5) regulates tau exon 10 splicing by
modulating a stem-loop structure at the 50 splice site. Mol. Cell. Biol. 31,
1812–1821.
Katz, Y., Wang, E.T., Airoldi, E.M., and Burge, C.B. (2010). Analysis and design
of RNA sequencing experiments for identifying isoform regulation. Nat.
Methods 7, 1009–1015.
Laurent, F.X., Sureau, A., Klein, A.F., Trouslard, F., Gasnier, E., Furling, D., and
Marie, J. (2012). New function for the RNA helicase p68/DDX5 as a modifier of
MBNL1 activity on expandedCUG repeats. Nucleic Acids Res. 40, 3159–3171.
Lim, L.P., and Burge, C.B. (2001). A computational analysis of sequence fea-
tures involved in recognition of short introns. Proc. Natl. Acad. Sci. USA 98,
11193–11198.
Lin, J.C., and Tarn, W.Y. (2011). RBM4 down-regulates PTB and antagonizes
its activity in muscle cell-specific alternative splicing. J. Cell Biol. 193,
509–520.
Lin, C., Yang, L., Yang, J.J., Huang, Y., and Liu, Z.R. (2005). ATPase/helicase
activities of p68 RNA helicase are required for pre-mRNA splicing but not for
assembly of the spliceosome. Mol. Cell. Biol. 25, 7484–7493.
Linder, P., and Jankowsky, E. (2011). From unwinding to clamping—the DEAD
box RNA helicase family. Nat. Rev. Mol. Cell Biol. 12, 505–516.
Mallinjoud, P., Villemin, J.P., Mortada, H., Polay Espinoza, M., Desmet, F.O.,
Samaan, S., Chautard, E., Tranchevent, L.C., and Auboeuf, D. (2014). Endo-
thelial, epithelial, and fibroblast cells exhibit specific splicing programs inde-
pendently of their tissue of origin. Genome Res. 24, 511–521.
Merkin, J., Russell, C., Chen, P., and Burge, C.B. (2012). Evolutionary dy-
namics of gene and isoform regulation in mammalian tissues. Science 338,
1593–1599.
Paul, S., Dansithong, W., Jog, S.P., Holt, I., Mittal, S., Brook, J.D., Morris, G.E.,
Comai, L., and Reddy, S. (2011). Expanded CUG repeats dysregulate RNA
splicing by altering the stoichiometry of the muscleblind 1 complex. J. Biol.
Chem. 286, 38427–38438.
Paz, I., Akerman, M., Dror, I., Kosti, I., and Mandel-Gutfreund, Y. (2010).
SFmap: aweb server formotif analysis and prediction of splicing factor binding
sites. Nucleic Acids Res. 38, W281–W285.
Rao, P.K., Kumar, R.M., Farkhondeh, M., Baskerville, S., and Lodish, H.F.
(2006). Myogenic factors that regulate expression of muscle-specific micro-
RNAs. Proc. Natl. Acad. Sci. USA 103, 8721–8726.
Samaan, S., Tranchevent, L.C., Dardenne, E., Polay Espinoza, M., Zonta, E.,
Germann, S., Gratadou, L., Dutertre, M., and Auboeuf, D. (2014). The Ddx5
and Ddx17 RNA helicases are cornerstones in the complex regulatory array
of steroid hormone-signaling pathways. Nucleic Acids Res. 42, 2197–2207.
Samatanga, B., Dominguez, C., Jelesarov, I., and Allain, F.H. (2013). The high
kinetic stability of a G-quadruplex limits hnRNP F qRRM3 binding to G-tract
RNA. Nucleic Acids Res. 41, 2505–2516.
Schor, I.E., Go´mez Acun˜a, L.I., and Kornblihtt, A.R. (2013). Coupling between
transcription and alternative splicing. Cancer Treat. Res. 158, 1–24.
Shapiro, I.M., Cheng, A.W., Flytzanis, N.C., Balsamo, M., Condeelis, J.S., Ok-
tay, M.H., Burge, C.B., and Gertler, F.B. (2011). An EMT-driven alternative
splicing program occurs in human breast cancer and modulates cellular
phenotype. PLoS Genet. 7, e1002218.
Suzuki, H.I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., andMiyazono,
K. (2009). Modulation of microRNA processing by p53. Nature 460, 529–533.
Thiery, J.P., Acloque, H., Huang, R.Y., and Nieto, M.A. (2009). Epithelial-
mesenchymal transitions in development and disease. Cell 139, 871–890.
Wang, E., and Cambi, F. (2009). Heterogeneous nuclear ribonucleoproteins H
and F regulate the proteolipid protein/DM20 ratio by recruiting U1 small nu-
clear ribonucleoprotein through a complex array of G runs. J. Biol. Chem.
284, 11194–11204.
Wang, B., Hsu, S.H., Majumder, S., Kutay, H., Huang, W., Jacob, S.T., and
Ghoshal, K. (2010a). TGFbeta-mediated upregulation of hepatic miR-181b
promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29,
1787–1797.
Wang, Z., Kayikci, M., Briese, M., Zarnack, K., Luscombe, N.M., Rot, G., Zu-
pan, B., Curk, T., and Ule, J. (2010b). iCLIP predicts the dual splicing effects
of TIA-RNA interactions. PLoS Biol. 8, e1000530.
Wang, D., Huang, J., and Hu, Z. (2012a). RNA helicase DDX5 regulates micro-
RNA expression and contributes to cytoskeletal reorganization in basal breast
cancer cells. Mol. Cell. Proteomics 11, M111.011932.
Wang, E., Aslanzadeh, V., Papa, F., Zhu, H., de la Grange, P., and Cambi, F.
(2012b). Global profiling of alternative splicing events and gene expression
regulated by hnRNPH/F. PLoS ONE 7, e51266.
Warner, D.R., Bhattacherjee, V., Yin, X., Singh, S., Mukhopadhyay, P., Pisano,
M.M., and Greene, R.M. (2004). Functional interaction between Smad, CREB
binding protein, and p68 RNA helicase. Biochem. Biophys. Res. Commun.
324, 70–76.CWarzecha, C.C., Jiang, P., Amirikian, K., Dittmar, K.A., Lu, H., Shen, S., Guo,
W., Xing, Y., and Carstens, R.P. (2010). An ESRP-regulated splicing pro-
gramme is abrogated during the epithelial-mesenchymal transition. EMBO J.
29, 3286–3300.
Xiao, X., Wang, Z., Jang, M., Nutiu, R., Wang, E.T., and Burge, C.B. (2009).
Splice site strength-dependent activity and genetic buffering by poly-G runs.
Nat. Struct. Mol. Biol. 16, 1094–1100.
Xiao, S., Zhang, J.Y., Zheng, K.W., Hao, Y.H., and Tan, Z. (2013). Bioinformatic
analysis reveals an evolutional selection for DNA:RNA hybrid G-quadruplex
structures as putative transcription regulatory elements in warm-blooded an-
imals. Nucleic Acids Res. 41, 10379–10390.
Yang, L., Lin, C., and Liu, Z.R. (2006). P68 RNA helicase mediates PDGF-
induced epithelial mesenchymal transition by displacing Axin from beta-cate-
nin. Cell 127, 139–155.
Zhang, X.H., Leslie, C.S., and Chasin, L.A. (2005). Dichotomous splicing sig-
nals in exon flanks. Genome Res. 15, 768–779.
Zonta, E., Bittencourt, D., Samaan, S., Germann, S., Dutertre, M., and Au-
boeuf, D. (2013). The RNA helicase DDX5/p68 is a key factor promoting c-
fos expression at different levels from transcription to mRNA export. Nucleic
Acids Res. 41, 554–564.ell Reports 7, 1900–1913, June 26, 2014 ª2014 The Authors 1913
